SLNO icon

Soleno Therapeutics

13 hedge funds and large institutions have $8.18M invested in Soleno Therapeutics in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
4
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VC
1
Vivo Capital
California
$7.36M 14,695,264
Deutsche Bank
2
Deutsche Bank
Germany
$288K 575,753 +569 +0.1%
PAI
3
Palo Alto Investors
California
$212K 423,738
SM
4
Sabby Management
Florida
$127K 248,067 +14,129 +6%
BG
5
Bollard Group
Massachusetts
$96K 192,217 -173,099 -47%
BlackRock
6
BlackRock
New York
$39K 77,596 +508 +0.7%
Vanguard Group
7
Vanguard Group
Pennsylvania
$30K 58,014 -9,756 -14%
Goldman Sachs
8
Goldman Sachs
New York
$15K 28,946 +7 +0%
Northern Trust
9
Northern Trust
Illinois
$7K 14,376
Bank of America
10
Bank of America
North Carolina
$3K 6,851 +6,851 New
UBS Group
11
UBS Group
Switzerland
$2K 4,343 +4,343 New
Morgan Stanley
12
Morgan Stanley
New York
$1K 1,400
Creative Planning
13
Creative Planning
Kansas
$1K 1,300 +1,300 New
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
-29,700 Closed
Citadel Advisors
15
Citadel Advisors
Florida
-24,525 Closed